Fol. Biol. 2004, 50, 131-135
https://doi.org/10.14712/fb2004050030131
Non-proliferative Interactions of Epstein-Barr Virus and Human B Lymphocytes
References
1. , J., Lewin, N., Yamamoto, K., Tomita, Y., Mellstedt, H., Brodin, B., Rosén, A., Klein, E. (1994) EBV infection of B-CLL cells in vitro potentiates their allostimulatory capacity if accompanied by acquisition of the activated phenotype. Int. J. Cancer 58, 678-685.
<https://doi.org/10.1002/ijc.2910580511>
2. , J., Lewin, N., Tomita, Y., Szeles, A., Sandlund, A., Mosolits, S., Mellstedt, H., Klein, G., Klein, E. (1997) B-CLL cells with unusual properties. Int. J. Cancer 70, 18.
<https://doi.org/10.1002/(SICI)1097-0215(19970106)70:1<1::AID-IJC1>3.0.CO;2-1>
3. Bandobashi, K., Liu, A., Nagy, N., Kis, L. L., Nishikawa, J., Taguchi, H., Miyoshi, I., Björkholm, B., Klein, G., Klein, E. EBV infection in B-CLL cells does not activate ATF-2, c-jun and Akt. To be published.
4. , A., Spieker, T., Mottok, A., Baur, A. S., Küppers, R., Hansmann, M. L. (2003) Epstein-Barr virus (EBV)positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes. Eur. J. Immunol. 33, 1593-1602.
<https://doi.org/10.1002/eji.200323765>
5. , F., Hamblin, T. J. (1999) B-cell chronic lymphocytic leukemia: a bird of different feather. J. Clin. Oncol. 17, 399-408.
<https://doi.org/10.1200/JCO.1999.17.1.399>
6. , F., Zou, J. Z., di Renzo, L., Winberg, G., Hu, L. F., Klein, E., Klein, G., Ernberg, I. (1995) A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J. Virol. 69, 3752-3758.
<https://doi.org/10.1128/jvi.69.6.3752-3758.1995>
7. , K. C., Gaspar, H. B. (2003) Pathogenesis and diagnosis of X-linked lymphoproliferative disease. Expert Rev. Mol. Diagn. 3, 549-561.
<https://doi.org/10.1586/14737159.3.5.549>
8. , E., Koh, E., Mosalios, G., Tong, X., Kieff, E., Grossman, S. R. (1995) Epstein Barr virus nuclear protein-2 transactivation of the latent membrane protein-1 promoter is mediated by J kappa and PU.1. J. Virol. 69, 253-262.
<https://doi.org/10.1128/jvi.69.1.253-262.1995>
9. , K. M., Izumi, K. M., Kieff, E. (1993) Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 90, 9150-9154.
<https://doi.org/10.1073/pnas.90.19.9150>
10. Kis, L. L., Nishikawa, J., Takahara, M., Nagy, N., Takada, K., Emberger, P. G., Ohlsson, A., Klein, G., Klein, E. The in vitro EBV-infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1; CD40-ligand and IL-4 induced LMP-1 but not EBNA-2. Int. J. Cancer (in press)
11. , G. (1994) Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 77, 791-793.
<https://doi.org/10.1016/0092-8674(94)90125-2>
12. , J., Hansmann, M. L., Rajewsky, K., Küppers, R. (2000) Epstein-Barr virus infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction. Proc. Natl. Acad. Sci. USA 100, 4730-4735.
<https://doi.org/10.1073/pnas.2627966100>
13. , R. (2002) Molecular biology of Hodgkinís lymphoma. Adv. Cancer Res. 84, 277-312.
<https://doi.org/10.1016/S0065-230X(02)84009-X>
14. , R. (2003) B cells under influence: transformation of B cells by Epstein-Barr virus. Nat. Rev. Immunol. 3, 801-812.
<https://doi.org/10.1038/nri1201>
15. , R., Schwering, I., Bräuninger, A., Rajewsky, K., Hansmann, M. L. (2002) Biology of Hodgkinís lymphoma. Ann. Oncol. 13, 11-18.
<https://doi.org/10.1093/annonc/13.S1.11>
16. , N., Avila-Carino, J., Minarovits, J., Lenette, E., Brautbar, C., Mellstedt, H., Klein, G., Klein, E. (1995) Detection of two Epstein-Barr-virus (EBV)-carrying leukemic cell clones in a patient with chronic lymphocytic leukemia (CLL). Int. J. Cancer 61, 159-164.
<https://doi.org/10.1002/ijc.2910610203>
17. , A., Bandobashi, K., Nagy, N., Teramoto, N., Gogolák, P., Pokrovskaja, K., Székely, L., Björkholm, M., Klein, G., Klein, E. (2001) Epstein-Barr virus can infect B-chronic lymphocytic leukaemia cells but it does not orchestrate the cell cycle regulatory proteins. J. Hum. Virol. 4, 227-237.
18. , G., Agathanggelou, A., Herbst, H., Whitehead, L., Wright, D. H., Young, L. S. (1997) Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells. J. Pathol. 182, 151-159.
<https://doi.org/10.1002/(SICI)1096-9896(199706)182:2<151::AID-PATH824>3.0.CO;2-3>
19. Rickinson, A. B., Kieff, E. (2001) Epstein-Barr virus. In: Fields Virology, eds. Fields, B. N., Knipe, D. M., Howley, P. M., pp. 2575-2627, Lippincot-Raven, Philadelphia.
20. , A. B., Moss, D. (1997) Human cytotoxic T lymphocyte responses to Epstein Barr virus infection. Annu. Rev. Immunol. 15, 405-431.
<https://doi.org/10.1146/annurev.immunol.15.1.405>
21. , T., Kurth, J., Küppers, R., Rajewsky, K., Bräuninger, A., Hansmann, M. L. (2000) Molecular single-cell analysis of the clonal relationship of small Epstein-Barr virusinfected cells and Epstein-Barr virus-harboring Hodgkin and Reed/Sternberg cells in Hodgkin disease. Blood 96, 3133-3138.
<https://doi.org/10.1182/blood.V96.9.3133>
22. , K., Yamamoto, K., Osato, T. (1980) Analysis of the transformation of human lymphocytes by Epstein-Barr virus. II. Abortive response of leukemic cells to the transforming virus. Intervirology 13, 223-231.
<https://doi.org/10.1159/000149129>
23. , N., Gogolák, P., Nagy, N., Maeda, A., Kvarnung, K., Björkholm, T., Klein, E. (2000) Epstein-Barr virusinfected B-chronic lymphocyte leukaemia cells express the virally encoded nuclear proteins but they do not enter the cell cycle. J. Hum.Virol. 3, 125-136.
24. , Y., Avila-Carino, J., Yamamoto, K., Mellstedt, H., Klein, E. (1998) Recognition of B-CLL cells experimentally infected with EBV by autologous T lymphocytes. Immunol. Lett. 60, 73-79.
<https://doi.org/10.1016/S0165-2478(97)00142-9>
25. , L. S., Murray, P. G. (2003) Epstein-Barr virus and oncogenesis: from latent genes to tumors. Oncogene 22, 5108-5121.
<https://doi.org/10.1038/sj.onc.1206556>
26. , E. V., Doyle, M. G., Patel, K. K., Allday, M. J., Catovsky, D., Crawford, D. H. (1989) Activation and immortalization of leukaemic B cells by Epstein-Barr virus. Int. J. Cancer 44, 846-853.
<https://doi.org/10.1002/ijc.2910440517>
